API Synthesis and Manufacturing, Large Molecule

Advanced Manufacturing Technologies Shift Outside the Box

April 03, 2021

Intensified and distributed manufacturing approaches create flexible, local capacity.

rBIO Hits Key Lab Milestone with Synthetic Production of Insulin

January 04, 2021

Using rDNA technology to synthesize production of proteins and peptide hormones, the biotech startup has achieved synthetic production of insulin, potentially lowering insulin cost by 30%.

Factoring Stability in the Biologic Drug Mix

October 03, 2020

Excipients must be carefully chosen to ensure optimum protection for vaccines and live biotherapeutic products.

CARBOGEN AMCIS Invests Heavily in Switzerland and France

August 20, 2020

CARBOGEN AMCIS has announced significant investments to increase manufacturing capacity in Switzerland and France.

CordenPharma Increases US Peptide Manufacturing Capacity

July 08, 2020

CordenPharma added a 3000-L solid-phase peptide synthesis vessel to its GMP API facility in Boulder, CO.

Can RNA Simplify Gene Therapy Development?

July 02, 2020

RNA is easier to manipulate than DNA but challenging to deliver to the right cells.

Novavax Contracts to Expand Adjuvant Production

June 04, 2020

Agreements with the PolyPeptide Group and AGC Biologics will scale up production of the Novavax Matrix-M adjuvant.

Formulating an ADC Development Solution

May 02, 2020

Many antibody-drug conjugate therapies are in the pipeline; however, only a handful have been approved. What are the bottlenecks?

Can Vaccine Development Be Safely Accelerated?

April 02, 2020

Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.

Bovine Heparin Meets Acceptable Impurity Levels

February 17, 2020

An evaluation by USP indicates bovine heparin is a potential alternative to porcine heparin.